WoundSource Section Logos - White Papers

Sorbact® Technology: How the Safe, Efficacious Topical Antimicrobial Dressing Technology Supports Better Outcomes

BSN white paper cover
 

Over 50% of current surgical site infections can be resistant to antibiotics, with resulting increases in morbidity, mortality, and costs. Systemic antibiotics may be losing their efficacy, but health care professionals have other tools to combat wound infection. By shifting the focus in advanced wound care to local wound management and infection prevention, wound care practitioners can meet antimicrobial stewardship objectives and thereby reduce reliance on broad-spectrum antibiotics. Unlike chemical-based topical agents, Sorbact® Technology has a physical mechanism of action. It avoids resistance issues associated with traditional antimicrobial dressings while providing broad-spectrum protection against microbes.

This guide begins with an overview of the worldwide scope of antimicrobial resistance. It then provides health care professionals with information on Sorbact® Technology, which offers a safe and effective alternative to other topical antimicrobial dressings, even in children and for prolonged durations.

The following topics are discussed:

Impacts of multidrug-resistant organisms on antibiotic effectiveness
Risks associated with drug-resistant surgical site infections
Economic costs of antimicrobial resistance
Focus on local wound management and infection prevention
Risks of chemical-based topical antimicrobials
Sorbact® Technology’s innovative mechanism of action
Pathogen binding with Sorbact® Technology
Safety and effectiveness of Sorbact® Technology

This white paper is generally written for wound care providers and other health care professionals with an interest in antimicrobial stewardship and infection prevention.

Sponsored by BSN Medical, an Essity Company

Over 50% of current surgical site infections can be resistant to antibiotics, with resulting increases in morbidity, mortality, and costs. Systemic antibiotics may be losing their efficacy, but health care professionals have other tools to combat wound infection. By shifting the focus in advanced wound care to local wound management and infection prevention, wound care practitioners can meet antimicrobial stewardship objectives and thereby reduce reliance on broad-spectrum antibiotics. Unlike chemical-based topical agents, Sorbact® Technology has a physical mechanism of action. It avoids resistance issues associated with traditional antimicrobial dressings while providing broad-spectrum protection against microbes.

This guide begins with an overview of the worldwide scope of antimicrobial resistance. It then provides health care professionals with information on Sorbact® Technology, which offers a safe and effective alternative to other topical antimicrobial dressings, even in children and for prolonged durations.

The following topics are discussed:

Impacts of multidrug-resistant organisms on antibiotic effectiveness
Risks associated with drug-resistant surgical site infections
Economic costs of antimicrobial resistance
Focus on local wound management and infection prevention
Risks of chemical-based topical antimicrobials
Sorbact® Technology’s innovative mechanism of action
Pathogen binding with Sorbact® Technology
Safety and effectiveness of Sorbact® Technology

This white paper is generally written for wound care providers and other health care professionals with an interest in antimicrobial stewardship and infection prevention.

Sponsored by BSN Medical, an Essity Company

WoundSource
The World’s Definitive Source for Wound Care & Product Information